Trial intelligence / Profile preview

KAART: HAART vs HAART + Chemotherapy in HIV-associated Kaposi's Sarcoma

NCT00380770Phase 4Completed

Sponsor
University of KwaZulu-Natal
Start
Jan 2003
Primary completion
Feb 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of stavudine, lamivudine, nevirapine in Kaposi sarcoma (KS), sponsored by University of KwaZulu-Natal. Started Jan 2003; status: completed.

02

Drugs

stavudinelamivudinenevirapine
03

Conditions

Kaposi sarcoma (KS)

Beyond the preview

Go deeper on NCT00380770.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00380770.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call